PD 0200390 Dose-Ranging Trial: A Randomized, Double-Blind, Placebo-Controlled, 4-Way Crossover, Multicenter Polysomnography Trial Of PD 0200390 In Elderly Subjects With Primary Insomnia.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2009
At a glance
- Drugs Atagabalin (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Pfizer
- 11 Feb 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 24 Sep 2008 New trial record.